Terminated
Studies With 1,25-Dihydroxycholecalciferol
Led by National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · Updated on 2013-11-25
6
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Vitamin D in the diet undergoes changes in the liver and kidneys to several forms. Patients suffering from disorders with Vitamin D resistance are unable to absorb calcium from food. Patients diagnosed with these disorders will be evaluated and treated with high doses of another form of Vitamin D (1,25-dihydroxyvitamin D3). Patients will be monitored and observed throughout the study to avoid experiencing side effects from the medication.
CONDITIONS
Brief Title
Studies With 1,25-Dihydroxycholecalciferol
Who Can Participate
Eligibility Criteria
- INCLUSION CRITERIA:
Patients with hereditary resistance to calcitrol.
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here